Limulus amebocyte lysate

Last updated

Atlantic horseshoe crab Limulus polyphemus Remembering the Sea (6224395337).jpg
Atlantic horseshoe crab Limulus polyphemus

Limulus amebocyte lysate (LAL) is an aqueous extract of motile blood cells (amebocytes) from the Atlantic horseshoe crab Limulus polyphemus. LAL reacts with bacterial endotoxins such as lipopolysaccharides (LPS), which are components of the bacterial capsule, the outermost membrane of cell envelope of gram-negative bacteria. This reaction is the basis of the LAL test, which is widely used for the detection and quantification of bacterial endotoxins.

Contents

In Asia, a similar Tachypleus amebocyte lysate (TAL) test based on the local horseshoe crabs Tachypleus gigas or Tachypleus tridentatus is occasionally used instead. [1] The recombinant factor C (rFC) assay is a replacement of LAL and TAL based on a similar reaction. [2]

Background

The American medical researcher Fred Bang reported in 1956 that gram-negative bacteria, even if killed, will cause the blood of the horseshoe crab to turn into a gel, a type of semi-solid mass. It was later recognized that the animal's blood cells, mobile cells called amebocytes, contain granules with a clotting factor known as coagulogen; this is released outside the cell when bacterial endotoxins are encountered. After coagulation and subsequent gelling, the resulting gel is thought to contain bacterial infections in the animal's semi-closed circulatory system. [3] Modern analysis of the lysate has led to understanding of this system of cascade, with multiple enzymes working in sequence to produce the gel. The entry point of endotoxin-induced clotting is Limulus clotting factor C. [4]

In 1977 the U.S. Food and Drug Administration (FDA) approved LAL for testing drugs, products and devices that come in contact with blood. Prior to that date, a much slower and more expensive test on rabbits had been used for this purpose. [5]

Horseshoe crabs are collected and blood is removed from the horseshoe crab's pericardium; some crabs are then returned to the water, while others are sold to be eaten or used as bait. Companies extracting LAL from horseshoe crabs stated before 2008 that mortality rates were below 3%. [6] A 2009 Massachusetts Division of Marine Fisheries study stated that earlier studies found 5 to 15% mortality for males and one estimate of 29% for females. The study itself found 22% for females returned immediately to the water, and 30% for females kept overnight to represent commercial practice. [7] The blood cells are separated from the serum using centrifugation and are then placed in distilled water, which causes them to swell and burst ("lyse"). This releases the chemicals from the inside of the cell (the "lysate"), which is then purified and freeze-dried. To test a sample for endotoxins, it is mixed with lysate and water; endotoxins are present if coagulation occurs. [8]

The LAL test

There are three basic methodologies: gel-clot, turbidimetric, and chromogenic. The primary application for LAL is the testing of parenteral pharmaceuticals and medical devices that contact blood or cerebrospinal fluid. In the United States, the FDA has published a guideline for validation of the LAL test as an endotoxin test for such products. [9]

The LAL cascade is also triggered by (1,3)-β-D-glucan, via a different Factor G. Both bacterial endotoxins and (1,3)-β-D-glucan are considered pathogen-associated molecular patterns, or PAMPs, substances which elicit inflammatory responses in mammals. [10]

Overcoming inhibition and enhancement

One of the most time-consuming aspects of endotoxin testing using LAL is pretreating samples to overcome assay inhibition that may interfere with the LAL test such that the recovery of endotoxin is affected. If the product being tested causes the endotoxin recovery to be less than expected, the product is inhibitory to the LAL test. Products which cause higher than expected values are enhancing. Overcoming the inhibition and enhancement properties of a product is required by the FDA as part of the validation of the LAL test for use in the final release testing of injectables and medical devices. Proper endotoxin recovery must be proven before LAL can be used to release product. [11]

Alternatives

Recombinant factor C assay

The LAL test is a major source of animal product dependence in the biomedical industry, and a challenge to the Three Rs of science in relation to the use of animals in testing. With reports of higher-than anticipated mortality rates [7] it has been considered more ethical to devise alternatives to the test. [12] Since 2003, a recombinant protein substitute for use in the LAL test has been commercially available. Named the recombinant factor C (rFC) assay, it is based on the same Limulus clotting factor C protein, but produced by genetically modified insect cells (the specific factor C sequence used does not necessarily come from the Atlantic horseshoe crab). [5]

Instead of emulating the whole clotting pathway, rFC tests let factor C cleave a synthetic fluorogenic substrate, so that the sample lights up when endotoxin activates the factor. Since it does not contain factor G, (1,3)-β-D-glucan will not cause false-positives. As of 2018, available evidence shows that the rFC test is no worse than the LAL test. [13]

The adoption of the rFC test was slow, which began to change in 2012 when the US FDA and the European health ministry acknowledged it as an accepted alternative. Its lack of mention in Pharmacopeias remained an issue, as there was no good standard for running the test in production. [13] In 2016, it was added to the European Pharmacopoeia. [5] A patent on rFC also limited adoption until its expiration in 2018. [13]

On 1 June 2020, the United States Pharmacopeia (USP) decided to cancel the proposal to include recombinant technology for endotoxin testing in chapter 85, Bacterial Endotoxins, and start the development of a separate chapter that expands on the use, validation, and comparability of endotoxin tests based on recombinantly derived reagents. A separate guidance-only chapter 1085.1 was proposed by the USP, though comments and feedback published on 11 December 2020 show that pharmaceutical companies and the FDA do not support this chapter, and request for compendial status. [14]

Monocyte activation test

The monocyte activation test (MAT) is another proposed method to test for endotoxins based on monocytes in human blood. It measures the release of cytokines from these due to the presence of pyrogens, basically mirroring the process by which these toxins cause fever in humans (and rabbits, as in the original pyrogen test). [15] A protocol for the MAT test, using cultured cells, is described in the European Pharmacopoeia. [16]

A recent study employing genetically engineered monocytes was able to significantly enhance the sensitivity of monocyte-based detection assays by bringing down the assay-completion time from more than 20 hours to 2–3 hours. [17]

See also

Related Research Articles

<span class="mw-page-title-main">Coagulation</span> Process of formation of blood clots

Coagulation, also known as clotting, is the process by which blood changes from a liquid to a gel, forming a blood clot. It results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The process of coagulation involves activation, adhesion and aggregation of platelets, as well as deposition and maturation of fibrin.

<span class="mw-page-title-main">Disseminated intravascular coagulation</span> Medical condition where blood clots block small blood vessels

Disseminated intravascular coagulation (DIC) is a condition in which blood clots form throughout the body, blocking small blood vessels. Symptoms may include chest pain, shortness of breath, leg pain, problems speaking, or problems moving parts of the body. As clotting factors and platelets are used up, bleeding may occur. This may include blood in the urine, blood in the stool, or bleeding into the skin. Complications may include organ failure.

<span class="mw-page-title-main">Atlantic horseshoe crab</span> Species of arthropod

The Atlantic horseshoe crab, also known as the American horseshoe crab, is a species of horseshoe crab, a kind of marine and brackish chelicerate arthropod. It is found in the Gulf of Mexico and along the Atlantic coast of North America. The main area of annual migration is Delaware Bay along the South Jersey Delaware Bayshore.

<span class="mw-page-title-main">Lipopolysaccharide</span> Class of molecules found in the outer membrane of gram-negative bacteria

Lipopolysaccharide, now more commonly known as endotoxin, is a collective term for components of the outermost membrane of cell envelope of gram-negative bacteria, such as E. coli and Salmonella with a common structural architecture. Lipopolysaccharides (LPS) are large molecules consisting of three parts: an outer core polysaccharide termed the O-antigen, an inner core oligosaccharide and Lipid A, all covalently linked. In current terminology, the term endotoxin is often used synonymously with LPS, although there are a few endotoxins that are not related to LPS, such as the so-called delta endotoxin proteins produced by Bacillus thuringiensis.

An assay is an investigative (analytic) procedure in laboratory medicine, mining, pharmacology, environmental biology and molecular biology for qualitatively assessing or quantitatively measuring the presence, amount, or functional activity of a target entity. The measured entity is often called the analyte, the measurand, or the target of the assay. The analyte can be a drug, biochemical substance, chemical element or compound, or cell in an organism or organic sample. An assay usually aims to measure an analyte's intensive property and express it in the relevant measurement unit.

<span class="mw-page-title-main">Horseshoe crab</span> Family of basal chelicerates

Horseshoe crabs are arthropods of the family Limulidae and are the only surviving xiphosurans. Despite their name, they are not true crabs or even crustaceans. Rather, they are chelicerates. This makes them more closely related to arachnids like spiders, ticks, and scorpions. The body of a horseshoe crab is divided into three main parts: the cephalothorax, abdomen, and telson. The largest of these, the cephalothorax, houses most of the animal's eyes, limbs, and internal organs. It is also where the animal gets its name, as its shape somewhat resembles that of a horseshoe. Horseshoe crabs have changed little in appearance since they first evolved in the Triassic, earning them the title of "living fossil".

Sargramostim is a recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) that functions as an immunostimulator.

<span class="mw-page-title-main">Biotechnology in pharmaceutical manufacturing</span>

Biotechnology is the use of living organisms to develop useful products. Biotechnology is often used in pharmaceutical manufacturing. Notable examples include the use of bacteria to produce things such as insulin or human growth hormone. Other examples include the use of transgenic pigs for the creation of hemoglobin in use of humans.

Depyrogenation refers to the removal of pyrogens from solutions, most commonly from injectable pharmaceuticals.

<span class="mw-page-title-main">LOCAD</span>

The Lab-on-a-Chip Applications Development (LOCAD) element is a set of related lab-on-a-chip projects at NASA. The projects develop integrated lab-on-a-chip products in three areas related to space exploration: Environmental Control and Life Systems Support (ECLSS), Medical Systems, and Remote Exploration. NASA conducts activities related to these projects both at NASA Marshall Space Flight Center and aboard the International Space Station (ISS).

Lal is a surname and a given name.

<span class="mw-page-title-main">Amebocyte</span>

An amebocyte or amoebocyte is a motile cell in the bodies of invertebrates including cnidaria, echinoderms, molluscs, tunicates, sponges, and some chelicerates.

Human platelet lysate is a substitute supplement for fetal bovine serum (FBS) in experimental and clinical cell culture. It is a turbid, light-yellow liquid that is obtained from human blood platelets after freeze/thaw cycle(s). The freeze/thaw cycle causes the platelets to lyse, releasing a large quantity of growth factors necessary for cell expansion. hPL has the highest concentration of growth factors of any serum supplements. FBS-free cell culture media, e.g. with platelet lysate or chemically defined/ animal component free, are used for cell therapy or regenerative medicine. They are commercially available in GMP -quality which is generally basis for regulatory approval.

<span class="mw-page-title-main">Coagulin</span>

Coagulin is a gel-forming protein of hemolymph that hinders the spread of bacterial and fungal invaders by immobilizing them. It is produced in the coagulogen form before being cleaved into the active form through a serine proteinase cascade. It has been most extensively studied in horseshoe crabs. It has also been produced by other organisms, such as Bacillus coagulans I4 in a plasmid location. In human medicine, coagulation of coagulin is the basis of detection of bacterial endotoxin through the Limulus amebocyte lysate test for parenteral medications.

Limulus clotting factor overbar C is an enzyme. This enzyme catalyses the following chemical reaction

Limulus clotting factor B is an enzyme. This enzyme catalyses the following chemical reaction

Limulus clotting enzyme is an enzyme. This enzyme catalyses the following chemical reaction:

Polyglucan is any polysaccharide that contains glucan units. Specifically, polyglucan's are a structural polysaccharide. The basic polyglucan unit consists of a long linear chain of several hundred to many thousands D-glucose monomers attached with a type of covalent bond called, glycosidic bonds. The point of attachment is O-glycosidic bonds, where a glycosidic oxygen links the glycoside to the reducing end sugar. Polyglucans naturally occur in the cell walls of bacteria. Bacteria produce this polysaccharide in a cluster near the bacteria's cells. Polyglucan's are a source of beta-glucans. Structurally, beta 1.3-glucans are complex glucose homopolymers binding together in a beta-1,3 configuration.

<span class="mw-page-title-main">Fred Bang</span> Medical researcher

Frederik Barry Bang (1916–1981) was an American medical researcher who developed the Limulus amebocyte lysate (LAL) test for bacterial endotoxins. He was influential in applying marine biology to medical research, especially immunology.

Jack Levin is an American physician-scientist and hematologist who, with Fred Bang, developed the Limulus amebocyte lysate (LAL) test for bacterial endotoxins.

References

  1. ↑ Sheng J, Zhou J, Peng Y, Zhu Z, Chen L (1 January 2006). "Tachypleus Amebocyte Lysate Test Using in Transfusion Reaction". Chinese Journal of Nosocomiology (in Chinese).
  2. ↑ "Endotoxin Testing Manufacturers and Conservation". www.horseshoecrab.org. Retrieved 10 March 2020.
  3. ↑ Greer S. "Frederik Bang". JH Bloomberg School of Public Health. Johns Hopkins Bloomberg School of Public Health.
  4. ↑ Iwanaga S (May 2007). "Biochemical principle of Limulus test for detecting bacterial endotoxins". Proceedings of the Japan Academy. Series B, Physical and Biological Sciences. 83 (4): 110–9. Bibcode:2007PJAB...83..110I. doi:10.2183/pjab.83.110. PMC   3756735 . PMID   24019589.
  5. 1 2 3 Zhang S (9 May 2018). "The Last Days of the Blue-Blood Harvest". The Atlantic. Retrieved 15 May 2018.
  6. ↑ "Crash: A Tale of Two Species - The Benefits of Blue Blood". PBS. 10 June 2008.
  7. 1 2 Leschen AS, Correia SJ (March 2010). "Mortality in female horseshoe crabs (Limulus polyphemus) from biomedical bleeding and handling: implications for fisheries management" (PDF). Marine and Freshwater Behaviour and Physiology. 43 (2): 135–47. doi:10.1080/10236241003786873. S2CID   35152647. Archived from the original (PDF) on 14 June 2010.
  8. ↑ "The History of Limulus and Endotoxin". Marine Biological Laboratory. Archived from the original on 28 October 2008.
  9. ↑ "Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers". U.S. Food and Drug Administration. Retrieved 5 March 2019.
  10. ↑ Sandle T (August 2013). "Pharmaceutical product impurities: considering beta glucans". American Pharmaceutical Review. 16 (5 Supplement S1): 16–19.
  11. ↑ Williams KL, ed. (2007). Endotoxins pyrogens, LAL testing and depyrogenation (3rd ed.). New York: Informa Healthcare. p. 342. ISBN   978-1420020595 . Retrieved 7 March 2015. Proper endotoxin recovery must be proven before LAL can be used to release product.
  12. ↑ Gorman, Richard (2020). "Atlantic Horseshoe Crabs and Endotoxin Testing: Perspectives on Alternatives, Sustainable Methods, and the 3Rs (Replacement, Reduction, and Refinement)". Frontiers in Marine Science. 7. doi: 10.3389/fmars.2020.582132 . ISSN   2296-7745. PMC   7612741 . PMID   35591980.
  13. 1 2 3 Maloney T, Phelan R, Simmons N (October 2018). "Saving the horseshoe crab: A synthetic alternative to horseshoe crab blood for endotoxin detection". PLOS Biology. 16 (10): e2006607. doi: 10.1371/journal.pbio.2006607 . PMC   6200278 . PMID   30312293.
  14. ↑ https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/usp-nf-notices/1085-1-pf-comments-20201211.pdf [ bare URL PDF ]
  15. ↑ "Alternative Endotoxin Testing Methods". www.horseshoecrab.org.
  16. ↑ "Monocyte Activation Test: From Validation to GMP Lab testing". American Pharmaceutical Review.
  17. ↑ Seumen, Clovis H. T.; Tomasiunaite, Urte; Legler, Daniel F.; Hauck, Christof R. (2021). "Elimination of negative feedback in TLR signalling allows rapid and hypersensitive detection of microbial contaminants". Scientific Reports. 11 (1): 24414. doi:10.1038/s41598-021-03618-9. PMC   8709846 . PMID   34952917.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.